Item 16 of 46 (back to results) previous next bistratamide F A homodetic cyclic peptide that consists of L-threonine and L-valine and L-serine as the amino acid residues cyclised via amide bonds. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line

Current search: 08. Chemical Category: main group molecular entity [CHEBI:33579] > p-block molecular entity [CHEBI:33675] > carbon group molecular entity [CHEBI:33582] > organic molecular entity [CHEBI:50860] > organic amino compound [CHEBI:50047] > peptide [CHEBI:16670] > cyclic peptide [CHEBI:23449] > homodetic cyclic peptide [CHEBI:24613] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  biochemical uses [CHEBI:52206] (3306)   metabolite [CHEBI:25212] (2692)   secondary metabolite [CHEBI:26619] (2225)   bistratamide F [CHEBI:65505] (1) 05. Industrial Uses  05. Industrial Uses  pharmaceutical [CHEBI:52217] (1978)   drug [CHEBI:23888] (1930)   antineoplastic agent [CHEBI:35610] (760)   bistratamide F [CHEBI:65505] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   pnictogen molecular entity [CHEBI:33302] (10027)   nitrogen molecular entity [CHEBI:51143] (7930)   amide [CHEBI:32988] (1863)   primary amide [CHEBI:33256] (1586)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organonitrogen compound [CHEBI:35352] (6705)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organic amino compound [CHEBI:50047] (2472)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  chalcogen molecular entity [CHEBI:33304] (15225)   oxygen molecular entity [CHEBI:25806] (14414)   organooxygen compound [CHEBI:36963] (11352)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  carbon group molecular entity [CHEBI:33582] (23847)   organic molecular entity [CHEBI:50860] (23769)   heteroorganic entity [CHEBI:33285] (15197)   organonitrogen compound [CHEBI:35352] (6705)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organic amino compound [CHEBI:50047] (2472)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carboxamide [CHEBI:37622] (1381)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  organic amino compound [CHEBI:50047] (2472)   peptide [CHEBI:16670] (730)   cyclic peptide [CHEBI:23449] (75)   homodetic cyclic peptide [CHEBI:24613] (46)   bistratamide F [CHEBI:65505] (1)  polyatomic entity [CHEBI:36357] (18777)   molecule [CHEBI:25367] (11520)   cyclic compound [CHEBI:33595] (7817)   macrocycle [CHEBI:51026] (234)   bistratamide F [CHEBI:65505] (1) ChEBI Compound Accession Identifier:   [CHEBI:65505] ChEBI Compound Description:   A homodetic cyclic peptide that consists of L-threonine and L-valine and L-serine as the amino acid residues cyclised via amide bonds. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line ChEBI Compound Identification Number:   65505 ChEBI InChI Value:   InChI=1S/C25H36N6O5S/c1-10(2)16-23-26-14(8-35-23)20(32)30-18(12(5)6)25-27-15(9-37-25)21(33)28-17(11(3)4)24-31-19(13(7)36-24)22(34)29-16/h9-14,16-19H,8H2,1-7H3,(H,28,33)(H,29,34)(H,30,32)/t13-,14+,16+,17+,18+,19+/m1/s1 ChEBI InChIKey Value:   PVKWKGXPRJQDIZ-XZHCTYTHSA-N ChEBI Compound Name:   bistratamide F ChEBI SMILES Value:   [H][C@@]12COC(=N1)[C@@H](NC(=O)[C@@]1([H])N=C(O[C@@H]1C)[C@@H](NC(=O)c1csc(n1)[C@@H](NC2=O)C(C)C)C(C)C)C(C)C ChEBI Substance ID:   160645029 ChEBI URL:   ChEBI:65505 ChemSpider ID:   NS Ontomatica Chemical Accession Key (OnChAKey):   PVKWKGXPRJQDIZ_XZHCTYTHSA_N_000_000000 PubChem Compound ID:   11060498